NIH-funded research NIH-funded research

Aiming to Cure HIV by Boosting Early Immune Response and Clearing Hidden Cells

Official title: Delaney AIDS Research Enterprise to Cure HIV

Funded at University of California, San Francisco · NIH-11515078 · Data updated 2026-11-12

Researchers are testing a combination approach in people to reduce hidden HIV reservoirs while ART is ongoing and to help control the virus if treatment is stopped.

More AIDS research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of California, San Francisco
NIH-funded
Lab location1 site (San Francisco, United States)
Project startAugust 16, 2021
Project endMay 31, 2028
Funding year2026
Award (this year)$4,998,395
NIH project number4UM1AI164560-06
Project IDNIH-11515078 on NIH RePORTER

Who could benefit from this research

Could help

Adults with HIV who are on ART and undergoing planned strategies to study viral rebound and immune responses.

Less likely to help

People not on ART or those unwilling to participate in immune/early-rebound studies may not benefit.

What this research studies

The project seeks to coordinate a strong early immune response to prevent HIV rebound when ART is interrupted, while also making infected cells more visible to the immune system for clearance. It will study immune and viral features in people to identify how persistence happens and how to interrupt it. The team plans to test therapeutic strategies that make infected cells more susceptible to the body’s natural defenses, aiming for durable remission without ongoing therapy.

Why it matters

Potential benefit: If successful, this work could move toward lasting HIV remission and reduce dependence on continuous ART.

How similar studies have gone: Earlier findings show that combining immune modulation with strategies to expose infected cells can reduce reservoirs, but results in humans are still emerging.

Where this research is happening

  • University of California, San Francisco
    San Francisco, United States
    Active

Researchers

  • Principal investigator: Deeks, Steven Grant — University of California, San Francisco
  • Study coordinator: Deeks, Steven Grant

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.